Resultados de búsqueda - Kailun Wu

  • Mostrando 1 - 1 Resultados de 1
Limitar resultados
  1. 1
    Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

    Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies por Yuqi Wang, Quan Quan, Camille Gleason, Helin Yu, Lujia Peng, Yanshen Kang, Ling Jiang, Kailun Wu, Jie Pan, Moxiyele Bao, Qing Zhu, Meiqi Yi, Ming Fang, Yue Zheng, Ling Qiu, Bin Xu, Xiang Li, Jinfeng Song, Jiamu Sun, Zheng Zhang, Zijun Su, Jara Lin, Yuanyuan Xie, April Xu, Xiling Song, Chichi Huang, Zhirong Shen, Lai Wang, Jing Song

    Publicado 2023-12-01

    Pharmaceutical companies have recently focused on accelerating the timeline for initiating first-in-human (FIH) trials to allow quick assessment of biologic drugs. For example, a stable cell pool can be used to produce materials for the toxicology (Tox) study, reducing time to the clinic by 4–5 mont...

    Descripción completa

    Enlace del recurso
    Artículo

    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: